| Gene Name: |
CD55 |
| Species Reactivity: |
Human (Homo sapiens) |
| Synonyms: |
CR TC CROM |
| Uniprot: |
P08174 |
| Description: |
this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against |
| Storage and handling: |
Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
CD55 |
| Short name: |
Anti- CD55 |
| Species: |
Humans, Human |
| Alternative name: |
decay accelerating factor to measure complement (Cromer blood group), sapiens CD55 molecule, antibody to-H |
| Alternative to gene target: |
CD55 and IDBG-106331 and ENSG00000196352 and 1604, CD55 and IDBG-629269 and ENSBTAG00000006984 and 518609, CR and CROM and DAF and TC, Extracellular, alpha-beta T cell activation and biological process this GO :2000563 and positive regulation of CD4-positive, alpha-beta T cell cytokine production and biological process this GO :0043086 and negative regulation of catalytic activity and biological process this GO :0043434 and response to peptide hormone and biological process this GO :0045087 and innate immune response and biological process this GO :0045121 and membrane raft and cellular component this GO :0045730 and respiratory burst and biological process this GO :0045916 and negative regulation of complement activation and biological process this GO :0060137 and maternal process involved in parturition and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :2000516 and positive regulation of CD4-positive, alpha-beta T cell proliferation and biological process, classical pathway and biological process this GO :0007204 and positive regulation of cytosolic calcium ion concentration and biological process this GO :0007283 and spermatogenesis and biological process this GO :0008289 and lipid binding and molecular function this GO :0009615 and response to virus and biological process this GO :0009986 and cell surface and cellular component this GO :0016324 and apical plasma membrane and cellular component this GO :0030449 and regulation of complement activation and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0031664 and regulation of lipopolysaccharide-mediated signaling pathway and biological process this GO :0035743 and CD4-positive, decay accelerating factor for complement (Cromer blood group), lipid binding, this GO :0001618 and virus receptor activity and molecular function this GO :0004857 and enzyme inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006958 and complement activation, this GO :0001618 : virus receptor activity, this GO :0001618 : virus receptor activity and also this GO :0004857 : enzyme inhibitor activity and also this GO :0005515 : protein binding and also this GO :0008289 : lipid binding, this GO :0004857 : enzyme inhibitor activity, this GO :0005515 : protein binding, this GO :0008289 : lipid binding, CD55 molecule |
| Identity: |
2665 |
| Gene: |
CD55 |
More about : CD55 |
| Long gene name: |
CD55 molecule (Cromer blood group) |
| Synonyms gene: |
DAF |
| Synonyms gene name: |
Cromer blood group system) CD55 molecule, decay accelerating factor for complement (CD55, decay accelerating factor for complement (Cromer blood group) |
| Locus: |
1q32, 2 |
| Discovery year: |
2001-06-22 |
| GenBank acession: |
BC001288 |
| Entrez gene record: |
1604 |
| RefSeq identity: |
NM_000574 |
| Classification: |
Sushi domain containing CD molecules Blood group antigens |
| Havana BLAST/BLAT: |
OTTHUMG00000036255 |
| Locus Specific Databases: |
Blood Group Antigen Mutation Database CD55base: Mutation registry for Decay-accelerating factor (CD55) deficiency (previously known as DAFbase) LRG_127 |